|
Argireline
|
阿基瑞林
|
616204-22-9
|
|
Rosuvastatin methyl ester
|
瑞舒伐他汀甲酯.
|
147118-40-9
|
|
4-Chloromethyl-5-
meth-yl-1,3-dioxol-
2-one
|
4-氯甲基-5-甲基-1,3-二氧雜環(huán)戊烯-2-酮
|
80841-78-7
|
|
Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl-
imidazole-5-
carboxylate
|
4-(1-羥基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯
|
144689-93-0
|
|
Methyl 4'-bromomethyl biphenyl-2-carboxylate
|
4'-溴甲基-2-甲酸甲酯聯(lián)苯
|
114772-38-2
|
|
2-n-Propyl-4-methyl-6-(1-methylbenzimi-
dazole-2-yl)benz-
imidazole
|
2-正丙基-4-甲基-6-(1'-甲基苯并咪唑-2-基)苯并咪唑
|
152628-02-9
|
|
Valsartan methyl ester
|
纈沙坦甲酯
|
137863-17-3
|
|
Silodocin P-1 oxalate
|
西洛多辛氰基物草酸鹽
|
|
|
Rabamipide Na
|
瑞巴派特鈉
|
|
|
Dapoxetine free base
|
達泊西汀
|
119356-77-3
|
|
Tadanafil P-1
|
(1R,3R)-1-(1,3-苯并二氧戊環(huán)-5-基)-2-(氯乙?；?-2,3,4,9-四氫-1H-吡啶并[3,4-B]吲哚-3-羧酸甲酯
|
171489-59-1
|
|
Dantrolene free base
|
丹曲林
|
85008-71-5
|
|
Varenicline free base
|
伐倫克林游離堿
|
249296-44-4
|
|
N-(4-cyanophenyl)-
glycine
|
N-(4-氰基苯基)甘氨酸
|
42288-26-6
|
|
Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-
pyridin-2-yl-beta-
alaninate
|
N-[4-甲胺基-3-氨基苯酰基]-N-2-吡啶基- -丙氨酸乙酯
|
212322-56-0
|
|
Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-
methyl-1H-benz-
imidazol-5-yl)-
carbonyl]-N-pyridin-
2-yl-beta-alaninate
|
3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯
|
211915-84-3
|
|
(S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol
|
(S)-3 –(甲氧基甲基)-2,3 –二甲基丁- 1 - 醇
|
1217719-34-0
|
|
(R)-(2,3-dimethyl-3-((
triethylsilyl)
oxy)butyl)-
diphenylphosphine oxide
|
(R)?-(2,3 - 二甲基-3 -((三乙基甲硅烷基)氧基)丁基)二苯基氧化膦
|
1227926-70-6
|
|
(2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
|
(2S)-2 – ((1R,3aR,7aR)-4 – ((叔丁基二甲基甲硅烷基)氧基)-7a-甲基八氫-1H-茚-1-基)丙-1-醇
|
215509-33-4
|
|
(1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy
methoxy)-5,6-dimethylhept-3-en-2-yl)-7a-
methylhexahydro- 1H-inden-4(2H)-one
|
(1R,3aR,7aR)-八氫-1-[(1R,2E,?4S)-5-(甲氧基甲氧基)-1,4,5-三甲基-2-己烯-1-基]-7a-甲基-4氫-茚-4-酮
|
100858-26-2
|
|
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one
|
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-二甲基-6-?(三乙基硅氧基) 庚烷-3-烯-2-基)-7a- 甲基六氫-1氫-茚 4(2氫)-酮
|
950586-26-2
|
|
2-((3R,5R)-3,5-bis((
tert-butyldimethyl
silyl)-oxy) cyclohexylidene)
ethanol
|
2-(3R,5R)-3,5 - 雙((叔丁基二甲基甲硅烷基)氧基)亞環(huán)己基)乙醇
|
139356-37-9
|
|
(2-((3R,5R)-3,5-bis((
tert-butyldimethyl-
silyl)oxy)cyclohexyl-
idene)ethyl)diphenylphosphine oxide
|
(2 –((3R, 5R)-3,5 - 雙((叔丁基二甲基甲硅烷基)氧基)亞環(huán)己基)乙基)二苯基氧化膦
|
139356-39-1
|
|
ATB-4
|
2-氯-5-(三氟甲基)芐基溴
|
237761-77-2
|
|
Diallyl bisphenol A
|
2,2'-二烯丙基雙酚
|
1745-89-7
|
|
5,6-Dihydroxyindole
|
5,6-二羥基吲哚
|
3131-52-0
|
|
5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid
|
5,6-二羥基-1H-吲哚-2-羧酸
|
4790-08-3
|
|
(E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate
|
(E)-甲基-3-(2,2-甲基苯并[d][1,3]二氧基-5基-丙烯酸酯
|
2187481-85-0
|
|
Cis-Sertraline-D-Madenlic acid
|
Sertraline HCl related substance舍曲林相關(guān)物質(zhì)
|
|
|
Sitagliptin impurity 1~5
|
Sitagliptin related substance西格列汀相關(guān)物質(zhì)
|
1217809-78-3
|
|
Quinic acid
|
右旋奎寧酸
|
77-95-2
|
|
Phenethyl caffeate
|
咖啡酸苯乙酯
|
104594-70-9
|
|
ATB-9
|
安塞曲匹中間體
|
875444-10-3
|
|
Caffeic acid
|
咖啡酸
|
331-39-5
|
|
Landiolol impurity 1
|
鹽酸蘭地洛爾雜質(zhì)-1
|
1253907-85-5
|
|
Landiolol impurity 2
|
鹽酸蘭地洛爾雜質(zhì)-2
|
1253907-81-1
|
|
Landiolol impurity 3
|
鹽酸蘭地洛爾雜質(zhì)-3
|
1253907-83-3
|
|
Dabigatran amidine HCl
|
達比加群脒鹽酸鹽
|
211914-50-5
|
|
Indobufen impurity 2
|
吲哚布芬雜質(zhì) 2
|
36691-02-8
|
|
Indobufen impurity 3
|
吲哚布芬雜質(zhì) 3
|
203313-55-7
|
|
Sarpogrelate HCl
|
沙格雷酯鹽酸鹽
|
125926-17-2
|
|
BP984
|
1-(二甲基氨基)-3-[2-[2-(3-甲氧基苯基)乙基]苯氧基]-2-丙醇鹽酸鹽
|
135261-74-4
|
|
Crisaborole impurity 1
|
克立硼羅雜質(zhì) 1
|
906673-43-6
|
|
Crisaborole impurity 3
|
克立硼羅雜質(zhì) 3
|
888967-63-3
|
|
Sitagliptin impurity 1
|
西格列汀雜質(zhì) 1
|
1345822-87-8
|
|
Sitagliptin impurity 2
|
西格列汀雜質(zhì) 2
|
1345822-86-7
|
|
Sitagliptin impurity 3
|
西格列汀雜質(zhì) 3
|
823817-58-9
|
|
Sitagliptin impurity 5
|
西格列汀雜質(zhì) 5
|
837430-15-6
|
|
Lesinurad sodium
|
雷西納德鈉
|
1151516-14-1
|
|
de-bromo Lesinurad
|
雷西納德脫溴雜質(zhì)
|
1533519-93-5
|
|
Benserazide HCl
|
鹽酸芐絲肼
|
14919-77-8
|
|
Benserazide P-1
|
芐絲肼 P-1
|
1353749-74-2
|
|
Silodosin impurity 2
|
西洛多辛雜質(zhì) 2
|
175870-21-0
|
|
Rebamipide sodium salt
|
瑞巴派特鈉鹽
|
|
|
Rebamipide meta-Cl impurity
|
瑞巴派特間氯異構(gòu)體
|
90098-05-8
|
|
Roxatidine impurity 1
|
羅沙替丁雜質(zhì) 1
|
73279-04-6
|
|
Roxatidine impurity 4
|
羅沙替丁雜質(zhì) 4
|
97900-87-3
|
|
Elagolix impurity 1
|
噁拉戈利雜質(zhì) 1
|
2248628-93-3
|
|
Erdosteine
|
厄多司坦
|
84611-23-4
|
|
Ilaprazole
|
艾普拉唑
|
172152-36-2
|
|
Ilaprazole intermediate P-3
|
艾普拉唑中間體P-3
|
172152-53-3
|
|
Ilaprazole impurity 4
|
艾普拉唑雜質(zhì) 4
|
1018229-53-2
|
|
Fexuprazan P-4
|
非蘇拉贊 P-4
|
1902955-29-6
|
|
N-Bn Tegoprazan parent nucleus
|
N-芐基特戈拉贊母核
|
1640981-20-9
|
|
N-Ts Tegoprazan P-1
|
N-對甲苯磺?；馗昀?P-1
|
4942485-42-9
|
|
N-Bn Tegoprazan P-1
|
N-芐基特戈拉贊 P-1
|
|
|
R-Tegoprazan isomer
|
R-特戈拉贊異構(gòu)體
|
942195-56-4
|
|
Vonoprazan Fumarate
|
富馬酸沃諾拉贊
|
1260141-27-2
|
|
Deoxycholic acid P-1
|
去氧膽酸 P-1
|
181270-68-8
|
|
Deoxycholic acid impurity 2
|
去氧膽酸雜質(zhì) 2
|
69519-35-3
|
|
Sodium Picosulfate impurity A
|
匹可硫酸鈉雜質(zhì)A
|
32500-19-9
|
|
Diclofenac Epolamine impurity 2
|
雙氯芬酸依泊胺雜質(zhì) 2
|
13625-57-5
|
|
Diclofenac Epolamine impurity 4
|
雙氯芬酸依泊胺雜質(zhì) 4
|
127792-23-8
|
|
Diclofenac Epolamine impurity 7
|
雙氯芬酸依泊胺雜質(zhì) 7
|
172494-87-0
|
|
Pranoprofen impurity B
|
普拉洛芬雜質(zhì)B
|
52549-22-1
|
|
Raloxifene HCl P-1
|
甲基雷洛昔芬
|
84541-36-6
|
|
Glimepiride Cis isomer
|
格列美脲順勢異構(gòu)體
|
684286-46-2
|
|
Glimepiride methyl ester
|
格列美脲甲基酯雜質(zhì)
|
119018-30-3
|
|
Oseltamivir degradation impurity 1
|
奧司他韋降解雜質(zhì) 1
|
|
|
Oseltamivir degradation impurity 2
|
奧司他韋降解雜質(zhì) 2
|
|
|
Iodonitrotetrazolium chloride
|
碘硝基氯化四氮唑藍
|
146-68-9
|
|
1,1'-(4-amino-6-hydroxy-1,3-phenylene)bis(ethan-1-one)
|
|
79324-45-1
|
|
1,1'-(4-(allyloxy)-6-(ethylamino)-1,3-phenylene)bis(ethan-1-one)
|
乙酮, 1,1'-[4-(乙基氨基)-6-(2-丙烯基OXY)-1,3-苯基ENE]雙- (9CI)
|
79324-50-8
|
|
1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione
|
1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione
|
69998-14-7
|
|
Mavacamten
MYK461
(S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione
|
瑪伐凱泰
|
1642288-47-8
|
|
N-(2,4-diacetyl-5-hydroxyphenyl)acetamide
|
|
79324-44-0
|
|
5-amino-2-(propylthio)pyrimidin-4-ol
|
|
|
|
1,1'-(4-(ethylamino)-6-hydroxy-5-propyl-1,3-phenylene)bis(ethan-1-one)
|
乙酮, 1,1'-[4-(乙基氨基)-6-羥基-5-丙基-1,3-苯基ENE]雙- (9CI)
|
79324-51-9
|
|
6-chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione
|
馬伐凱泰中間體
|
887581-47-7
|
|
LCL161
|
LCL161
|
1005342-46-0
|
|
GDC-0276
|
GDC0276
|
1494581-70-2
|
|
GSK-2110183C impurity d-M14
|
福瑞賽替雜質(zhì)氘代M14
|
|
|
GSK-2110183C
|
福瑞賽替
|
1047644-62-1
|
|
Mefatinib
|
邁華替尼
|
1417695-74-9
|
|
GDC-0310 intermediate 1
|
GDC-0310中間體1
|
1788072-29-6
|
|
MK-1755 intermediate 4
|
1,2-二氫-1-[6-(1-羥基-1-甲基乙基)-2-吡啶]-6-(甲基硫代)-2-(2-丙烯-1-基)-3H-吡唑并[3,4-D]嘧啶-3-酮
|
955369-56-9
|
|
GDC-0310
|
GDC-0310
|
1788063-52-4
|
|
GDC-0310 intermediate 2
|
GDC-0310中間體2
|
1788072-30-9
|
|
Carbamic acid, N-?[(1S)?-?1-?cyclohexyl-?2-?[(2S)?-?2-?[4-?(4-?fluorobenzoyl)?-?2-?thiazolyl]?-?1-?pyrrolidinyl]?-?2-?oxoethyl]?-?, 1,?1-?dimethylethyl ester
|
LCL-161前體-C7
|
1005342-80-2
|
|
MK-1755 intermediate 2
|
MK-1755中間體2
|
2007908-48-5
|
|
MK-1755 intermediate 3
|
2-烯丙基-6-(甲基硫代)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮
|
955368-90-8
|
|
JH-VIII-157-02
|
化合物 T15612
|
1639422-97-1
|
|
GSK-2110183C impurity M14
|
福瑞賽替雜質(zhì)M14
|
|
|
(S)-(4-Fluorophenyl)(2-(pyrrolidin-2-yl)thiazol-4-yl)methanone hydrochloride
|
LCL-161前體-C6
|
1263876-35-2
|
|
Testosterone Tridecanoate
|
睪酮13烷酸酯
|
488836-58-4
|
|
GSK-2110183C intermediate
|
福瑞賽替羧酸中間體
|
1047630-61-4
|
|
MK-1755 intermediate 1
|
1-烯丙基肼甲酸叔丁酯
|
21075-86-5
|
|
Oxobutanedioic acid
|
草酰乙酸
|
328-42-7
|
|
L-Threonine, N-(4-ethynylbenzoyl)-, methyl ester
|
CHIR090-中間體1
|
728878-24-8
|
|
4-aMino-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide
|
4-氨基-3-甲氧基-N-(1-甲基哌啶-4-基)苯甲酰胺
|
876126-60-2
|
|
CHIR090
|
CHIR 090
|
728865-23-4
|
|
BI-2536 parent nucleus
|
(7R)-2-氯-8-環(huán)戊基-7-乙基-7,8-二氫-5-甲基-6(5H)-蝶啶酮
|
755039-55-5
|
|
MK-1755
|
MK-1775
|
955365-80-7
|
|
Sitagliptin impurity 4
|
西格列汀雜質(zhì) 4
|
823817-57-8
|
|
2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole
|
2,2-二甲基- 5H-[1,3]-二惡英[4,5-f]吲哚
|
437757-21-6
|
|
Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate
|
5,6-二羥基-1H-吲哚-2-羧酸甲酯
|
10131-14-3
|
|
ATB-1
|
2-氟-4-甲氧基-1-異丙基苯
|
1262414-96-9
|
|
(R)-(2,3-dimethyl-3-
butyl)diphenyl
phosphineoxide
|
(R)?-(3 -(甲氧基甲氧基)-2,3 -二甲基丁基)二苯基氧化膦
|
|
|
(S)-2,3-Dimethyl-3-((
triethylsilyl)oxy)butan-1-ol
|
(S)-2,3 - 二甲基-3 –((三乙基甲硅烷基)氧基)丁-1 - 醇
|
957997-83-0
|
|
L-Threonine, N-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]benzoyl]-, methyl ester
|
CHIR090-中間體1
|
728878-12-4
|
|
GDC-0310 intermediate 4
|
GDC-0310中間體4
|
2448100-15-8
|
|
Raloxifene impurity 1
|
雷洛昔芬雜質(zhì) 1
|
84541-37-7
|
|
Fexuprazan P-1
|
非蘇拉贊 P-1
|
1902955-31-0
|
|
d-Mefatinib
|
氘代邁華替尼
|
|
|
Elagolix impurity 3
|
噁拉戈利雜質(zhì) 3
|
2375499-61-7
|
|
GDC-0310 intermediate 3
|
|
|
|
4-methoxy-5-nitro-2-(propylthio)pyrimidine
|
|
2514951-26-7
|
|
4-chloro-5-nitro-2-(propylthio)pyrimidine
|
替格瑞洛雜質(zhì)15
|
2518331-26-3
|
|
1,1'-(4-(ethylamino)-6-hydroxy-1,3-phenylene)bis(ethan-1-one)
|
|
79324-49-5
|
|
Raloxifene impurity 2
|
雷洛昔芬雜質(zhì) 2
|
173773-26-7
|
|
Pranoprofen P-2
|
普拉洛芬 P-2
|
146330-68-9
|
|
Diclofenac Epolamine impurity 6
|
雙氯芬酸依泊胺雜質(zhì) 6
|
42088-52-8
|
|
Deoxycholic acid impurity 3
|
去氧膽酸雜質(zhì) 4
|
|
|
Deoxycholic acid impurity 1
|
去氧膽酸雜質(zhì) 1
|
|
|
Ilaprazole impurity 1
|
艾普拉唑雜質(zhì) 1
|
172152-37-3
|
|
Roxatidine impurity 3
|
羅沙替丁雜質(zhì) 3
|
78274-00-7
|
|
Crisaborole impurity 2
|
克立硼羅雜質(zhì) 2
|
1187188-59-5
|
|
Ilaprazole impurity 3
|
艾普拉唑雜質(zhì) 3
|
84445-90-9
|
|
Silodosin P-1 oxalate
|
西洛多辛P-1草酸鹽
|
1883697-83-3
|
|
Methyl caffeate
|
咖啡酸甲酯
|
67667-67-8
|